Ozempic (semaglutide)

Mike Doustdar Novo Nordisk Novo Novo CEO

Pharma

Novo Nordisk's 'optimistic' CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”

Fraiser Kansteiner Jun 11, 2026 7:00am

Measuring tape on top of cash

GLP-1s oust oncology as top late-stage pipeline value driver

May 4, 2026 7:00am

Novo Nordisk

Rybelsus brand retired in US as ‘Ozempic pill’ takes the stage

May 1, 2026 8:00am

Novo Nordisk

Novo eyes adolescent diabetes approval for oral semaglutide

Apr 23, 2026 11:03am

Flag of India on a pole and billowing in the wind Behind the flag is greenery

Generic versions of Novo's semaglutide launch today in India

Mar 20, 2026 11:27am

Novo Nordisk

Novo's US headquarters hit with FDA warning letter

Mar 10, 2026 11:40am